FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study
Köhne, C.-H, Poston, G, Folprecht, G, Ciardiello, F, Ronga, P, Beier, F, Van Cutsem, E
Published in European journal of surgical oncology (01.10.2016)
Published in European journal of surgical oncology (01.10.2016)
Get full text
Journal Article
PCN86 HEALTHCARE RESOURCE UTILIZATION FOR CETUXIMAB + CHEMOTHERAPY ADMINISTERED EVERY OTHER WEEK VS ONCE WEEKLY FOR TREATMENT OF METASTATIC COLORECTAL CANCER: REAL-WORLD OUTCOMES FROM A US CLAIMS DATABASE STUDY
Pescott, C., Batech, M., Boutmy, E., Ronga, P., Lamy, F.X.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
The influence of grain boundary angle on the hot cracking of single crystal superalloy DD6
Rong, P., Wang, N., Wang, L., Yang, R.N., Yao, W.J.
Published in Journal of alloys and compounds (15.08.2016)
Published in Journal of alloys and compounds (15.08.2016)
Get full text
Journal Article
33P Real-world experience of MET TKI-induced peripheral edema
Ferrara, R., Vansteenkiste, J.F., Yang, X., Grossi, F., Melosky, B., Ahn, M-J., Calles, A., Chan, O.S.H., Han, B., Bulusu, V.R., Califano, R., Nishino, K., Ghori, V., Ronga, P., Berghoff, K., Vlassak, S., Le, X.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
Biomarker testing practices in the SECURE (proSpective obsErvational clinical practiCe stUdy in the first-line management of metastatic colorectal cancer [mCRC] with eRbitux in combination with chemothErapy) study
Aravantinos, G., Shahrasbi, A., Oukkal, M., Larbaoui, B., Ronga, P., Messinger, D., Hamad, J., Benbrahim, W.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Folfiri Plus Cetuximab in Patients with Liver-Limited or Non-Liver-Limited Ras Wild-Type Metastatic Disease: a Sub-Group Analysis of the Crystal Study
Köhne, C., Folprecht, G., Ciardiello, F., Ronga, P., Beier, F., Van Cutsem, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
541PFOLFIRI PLUS CETUXIMAB IN PATIENTS WITH LIVER-LIMITED OR NON-LIVER-LIMITED RAS WILD-TYPE METASTATIC DISEASE: A SUB-GROUP ANALYSIS OF THE CRYSTAL STUDY
Köhne, C., Folprecht, G., Ciardiello, F., Ronga, P., Beier, F., Van Cutsem, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Performance assessment of blood based RAS mutation testing: Concordance of results obtained from prospectively collected samples
Saunders, M.P., Cooney, C., Edelstein, D., Mullamitha, S., Braun, M., Moghadam, S., Ronga, P., Jones, F.S., Telaranta-Keerie, A., Adams, R.A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS)
Krzemieniecki, K., Antolín Novoa, S., Gozy, M., Schumacher, C., Steger, G. G., Carteni', G., Bird, B. R., Albuisson, E., Barnadas, A., Batist, G., De Mouzon, J., Erdkamp, F., Leonard, R. C. F., Lueck, H., Namer, M., Venturini, M., Ronga, P., Maumus-Robert, S., Aapro, M. S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article